<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03125811</url>
  </required_header>
  <id_info>
    <org_study_id>E17005</org_study_id>
    <nct_id>NCT03125811</nct_id>
  </id_info>
  <brief_title>Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)</brief_title>
  <acronym>VOMIITED</acronym>
  <official_title>Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University Health Sciences Center, El Paso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Tech University Health Sciences Center, El Paso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare two different ways to relieve nausea and vomiting in the Emergency
      Department. The usual treatment for nausea/vomiting is a drug called Zofran, but new studies
      have suggested that smelling alcohol pads can also help to relieve nausea and vomiting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Emergency physicians commonly use medications to alleviate nausea and vomiting. The
      medication Ondansetron is used in the emergency department and after surgery for this
      purpose. Inhaled isopropyl alcohol has been successfully used to decrease nausea and vomiting
      after surgery. No trial has compared inhaled isopropyl alcohol to Ondansetron in a clinical
      trial.

      The author proposes to prospectively investigate extension of the established antiemetic
      efficacy of inhaled isopropyl alcohol for undifferentiated nausea in Emergency Department
      patients to the 30-minute post-intervention point that has been reported to be the frequent
      juncture of symptom relief. By introducing prolonged intervention, and re-dosing of
      established benefit, into this research, the author aims to reproduce the sustained
      antiemetic efficacy of inhaled isopropyl alcohol for undifferentiated nausea as demonstrated
      for post-operative nausea and vomiting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 17, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Nausea Severity</measure>
    <time_frame>60 minutes</time_frame>
    <description>Patient's nausea severity will be assessed at three time points by the study personnel using a verbal nausea rating scale over the course 60 minutes. Severity is scored 0-10 (0 = no nausea; 10 = severe nausea). Time points are at 0 minutes, 30 minutes, and 60 minutes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Emesis Event</measure>
    <time_frame>60 minutes</time_frame>
    <description>Total number of emesis will be recorded for the 60 minute participation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <arm_group>
    <arm_group_label>Inhaled Isopropyl Alcohol (IPA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inhaled Isopropyl Alcohol (alcohol prep pad)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Dissolvable Tablet Zofran (OZ)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>4 mg Oral Dissolvable Tablet Zofran (ondansetron)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inhaled Isopropyl Alcohol (IPA)</intervention_name>
    <description>Three doses within 60 minutes. Doses will occur at 0 minutes, 30 minutes, and 60 minutes. Each dose consists of 3 inhalations of one IPA prep pad. A new prep pad is used at each dose.</description>
    <arm_group_label>Inhaled Isopropyl Alcohol (IPA)</arm_group_label>
    <other_name>IPA</other_name>
    <other_name>alcohol prep pad</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral Dissolvable Tablet Zofran (ondansetron)</intervention_name>
    <description>Single dose 4 mg tablet at 0 minutes.</description>
    <arm_group_label>Oral Dissolvable Tablet Zofran (OZ)</arm_group_label>
    <other_name>OZ</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18-65 years presenting to the emergency department complaining of
             current nausea with or without episodes of emesis beginning within the previous 24hrs

        Exclusion Criteria:

          -  Patients with known allergy to isopropyl alcohol

          -  Patients outside of the defined age range

          -  Patients with an inability to inhale through the nares (including recent upper
             respiratory infection)

          -  Patients greater than 20 weeks estimated gestation

          -  Patients with past medical history of gastroparesis, or hemoptysis

          -  Patients who have taken an antiemetic medication in the past 48 hours

          -  Patients demonstrating hemodynamic instability with systolic blood pressure &lt;90 or
             tachycardia &gt;120 bpm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Crawford, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech Universtiy Health Sciences Center El Paso</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Scott Crawford, M.D.</last_name>
    <phone>915-215-4600</phone>
    <email>scott.crawford@ttuhsc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Texas Tech University Health Sciences Center El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medical Center</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Crawford, MD</last_name>
      <phone>915-215-4600</phone>
      <email>scott.crawford@ttuhsc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Myer PA, Mannalithara A, Singh G, Singh G, Pasricha PJ, Ladabaum U. Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States. Am J Gastroenterol. 2013 Sep;108(9):1496-507. doi: 10.1038/ajg.2013.199. Epub 2013 Jul 16.</citation>
    <PMID>23857475</PMID>
  </reference>
  <reference>
    <citation>Braude D, Soliz T, Crandall C, Hendey G, Andrews J, Weichenthal L. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. Am J Emerg Med. 2006 Mar;24(2):177-82.</citation>
    <PMID>16490647</PMID>
  </reference>
  <reference>
    <citation>Patanwala AE, Amini R, Hays DP, Rosen P. Antiemetic therapy for nausea and vomiting in the emergency department. J Emerg Med. 2010 Sep;39(3):330-6. doi: 10.1016/j.jemermed.2009.08.060. Epub 2009 Dec 21. Review.</citation>
    <PMID>20022195</PMID>
  </reference>
  <reference>
    <citation>Barrett TW, DiPersio DM, Jenkins CA, Jack M, McCoin NS, Storrow AB, Singleton LM, Lee P, Zhou C, Slovis CM. A randomized, placebo-controlled trial of ondansetron, metoclopramide, and promethazine in adults. Am J Emerg Med. 2011 Mar;29(3):247-55. doi: 10.1016/j.ajem.2009.09.028. Epub 2010 Mar 26.</citation>
    <PMID>20825792</PMID>
  </reference>
  <reference>
    <citation>Furyk JS, Meek RA, Egerton-Warburton D. Drugs for the treatment of nausea and vomiting in adults in the emergency department setting. Cochrane Database Syst Rev. 2015 Sep 28;(9):CD010106. doi: 10.1002/14651858.CD010106.pub2. Review.</citation>
    <PMID>26411330</PMID>
  </reference>
  <reference>
    <citation>Ohashi Y, Nakai Y, Ikeoka H, Koshimo H, Esaki Y, Horiguchi S, Teramoto K, Nakaseko H. An experimental study on the respiratory toxicity of isopropyl alcohol. J Appl Toxicol. 1988 Feb;8(1):67-71.</citation>
    <PMID>3356866</PMID>
  </reference>
  <reference>
    <citation>Gill MW, Burleigh-Flayer HD, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner TH. Isopropanol: acute vapor inhalation neurotoxicity study in rats. J Appl Toxicol. 1995 Mar-Apr;15(2):77-84.</citation>
    <PMID>7782562</PMID>
  </reference>
  <reference>
    <citation>Winston AW, Rinehart RS, Riley GP, Vacchiano CA, Pellegrini JE. Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea. AANA J. 2003 Apr;71(2):127-32.</citation>
    <PMID>12776641</PMID>
  </reference>
  <reference>
    <citation>Pellegrini J, DeLoge J, Bennett J, Kelly J. Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV. AANA J. 2009 Aug;77(4):293-9.</citation>
    <PMID>19731848</PMID>
  </reference>
  <reference>
    <citation>Hines S, Steels E, Chang A, Gibbons K. Aromatherapy for treatment of postoperative nausea and vomiting. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD007598. doi: 10.1002/14651858.CD007598.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Mar 10;3:CD007598.</citation>
    <PMID>22513952</PMID>
  </reference>
  <reference>
    <citation>Beadle KL, Helbling AR, Love SL, April MD, Hunter CJ. Isopropyl Alcohol Nasal Inhalation for Nausea in the Emergency Department: A Randomized Controlled Trial. Ann Emerg Med. 2016 Jul;68(1):1-9.e1. doi: 10.1016/j.annemergmed.2015.09.031. Epub 2015 Dec 8.</citation>
    <PMID>26679977</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2017</study_first_submitted>
  <study_first_submitted_qc>April 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Tech University Health Sciences Center, El Paso</investigator_affiliation>
    <investigator_full_name>Scott Crawford</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Isopropyl alcohol</keyword>
  <keyword>Zofran</keyword>
  <keyword>antiemetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

